Trivalent Seasonal Influenza Vaccine for Southern Hemisphere | 10-Dose Vial
ProcurenetShort description
This Trivalent Seasonal Influenza Vaccine is tailored specifically for the Southern Hemisphere. The 10-dose vial is a cost-effective solution with a 0.5 ml dosage.
- Optimized for Efficiency: Distributed in 10 doses per vial for efficient use.
- Cold Chain Standard Compliant: Ensures product viability via storage and shipping at 2-8°C, sustainable for a 6-month shelf life.
- Region-Specific Efficiency: Formulated to combat major influenza strains specific to the Southern Hemisphere.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Product Overview
Guard your health and the health of others this flu season with our Trivalent Seasonal Influenza Vaccine, optimally designed for the Southern Hemisphere. This vaccine yields superior protection by targeting predominant flu strains specific to this region.
Outstanding Features
- Regional Specificity: Offering heightened protection, this vaccine singularly focuses on the most common flu strains sweeping the Southern Hemisphere.
- Packaging Efficiency: Packaged in a 10-dose vial, this design minimizes waste and maximizes efficiency.
- Dosage Precision: Each dose is meticulously measured to 0.5 ml to adhere to safety and effectiveness standards.
Storage and Shipment
- Preservation: To maintain its potency, the vaccine should be stored at 2-8°C and protected from light. The vaccine must not be frozen.
- Transportation: Our forwarding services ensure the storage conditions are preserved during shipping, maintaining the vaccine's integrity.
Shelf Life and Packaging
- Shelf Life: A minimum shelf life of six months provides flexible usage and reduces wastage.
- Large-scale Distribution: The export packaging includes 1,200 vials, totalling 12,000 doses, making it perfect for large-scale immunization programs.
Choose our Trivalent Seasonal Influenza Vaccine to ensure maximum community health protection. Given the efficiency of usage and strategic target to prevalent flu strains in the Southern Hemisphere, this vaccine is an excellent choice for both practitioners and large-scale immunization programs.
